Zhu and his research team first analyzed the F proteins used in the development of four existing RSV vaccines—the commercially available Arexvy, mResvia and Abrysvo, and an experimental vaccine ...

High levels of neutralizing antibodies to RSV F protein have been shown to correlate with protection from RSV disease in infants and the elderly, and the clinical effectiveness of palivizumab and ...

The RSV F protein is a trimer in two different forms ... Standard laboratory instrumentation and methodologies were used to analyze protein structure conformation. Size-exclusion chromatography ...

BLB201 encodes the RSV F protein and uses a proprietary PIV5 vector, which is not known to cause human disease. PIV5 has been commonly administered to dogs as part of combination distemper/kennel ...

The F and G proteins are the only viral components that induce neutralizing antibodies and are the primary targets of the humoral response. RSV is a major seasonal viral respiratory pathogen in ...